Skip to content
type1.science

Medtrum TouchCare Nano CGM

Medtrum

What it is

A standalone or Medtrum-pump-integrated CGM with a rechargeable transmitter and up to 14-day sensor wear. It reports every two minutes and offers optional calibration.

Editorial review: . What was checked and what remains uncertain.

Source dates appear in the references where available; this record has no dated citation metadata.

Trial status, labels and access can change between reviews.

Full sources ↓Full discussion ↓Report an issue →

Available nowEarly evidenceOfficial site ↗

Evidence behind this assessment

Key evidence notes. Study results, product eligibility and access answer different questions.

Who was studied?
Study populations and analysis groups vary. Product age limits alone do not describe who was studied.
Benefit or performance
Accuracy: Comparative T1D accuracy not revalidated; conservative editorial assessment.[1]
Important harms and treatment burden
Read the safety discussion and original sources. A missing summary does not establish safety.
Approval and country access
Country-specific approval and access are not summarized in this record.Approval, trial recruitment, local supply and funding are separate. Check the cited label or access source.
Follow-up and remaining uncertainty
Read the record-specific review limits for gaps in evidence, source access or availability checks.

This record cites company or conference reports. Those sources may describe interim findings; their source type is shown in the source list.

Editorial score: calculation and evidence

A weighted editorial judgment on a 0–100 scale, not a probability of success or a measured treatment effect. Higher criterion scores mean more favorable assessments.

Default calculation: 45 × 20 + 45 × 15 + 50 × 15 + 85 × 10 + 88 × 10 + 70 × 10 + 75 × 10 + 0 × 5 + 60 × 5 = 5805; divide by total weight 100. Unrounded weighted result: 58.05.

Accuracy45

Comparative T1D accuracy not revalidated; conservative editorial assessment.[1]

Low lag45

Two-minute updates do not measure physiological lag.[1]

Interoperability50

Standalone use or integration with Medtrum pumps, subject to local compatibility.[1]

Sensor lifespan85

Up to 14-day wear.[1]

No calibration88

No routine calibration; optional calibration and mismatch fingerstick checks.[1]

Alerts & prediction70

Manufacturer describes configurable predictive alarms, not independently validated outcome benefit.[1]

Form factor75

Slim reusable rechargeable transmitter; additional charging burden.[1]

Ketone sensing0

Glucose only.[1]

Access & cost60

UK purchase and conditional NHS access confirmed; other countries not audited.[2]

Editor’s take

Scores are editorial judgments about the evidence and practical features, not measured comparative performance or a probability of success.

The full picture

The current manufacturer page identifies transmitter MD1158 and sensor MD3658. It describes up to 14-day wear, readings every two minutes, optional calibration, and configurable predictive high/low warnings. It can run independently with EasySense or integrate with compatible Medtrum pumps; regional models differ.1

The UK manufacturer offers a purchase route and states NHS access depends on eligibility. These sources do not establish a head-to-head accuracy advantage, universal funding or interoperability with other pump brands. The separate Medtrum AID record covers the algorithm and its evidence.2

References

  1. Medtrum TouchCare Nano CGM specifications, MD1158/MD3658. https://www.medtrum.com/product/nanocgm ↩

  2. Medtrum UK purchase and NHS access information. https://www.medtrum.co.uk/buynow.html ↩

Sources

  1. [1]Medtrum TouchCare Nano CGM specifications, MD1158/MD3658 · manufacturer
  2. [2]Medtrum UK purchase and NHS access information · manufacturer